• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Humana AB: Humana receives final competition clearance for the divestment of elderly care units in Finland

HUMRegulatory press release22.01.2025, 11.00
Download the release

On 23 May 2024, Humana announced that Humana Finland had entered into an agreement to divest 21 elderly care units to Mehiläinen Oy. Humana has now received final approval from the Finnish Competition Authority. The transaction is expected to be finalised and excluded from Humana's accounts from February 3, 2025.

The approval from the competition authority is conditional on Humana divesting one of the 21 units to a third party. Final approval has been obtained after Humana entered into an agreement with Esperi Care on the divestment of one unit. The total purchase price remains unchanged at EUR 25 million.

The operations employ approximately 430 FTEs and serve about 500 clients. In 2023, the reported full-year revenues were EUR 36.4 million, with an operating profit of EUR 2.7 million including allocated overhead.

For more information, please contact:
 

Nathalie Boulas Nilsson, President and CEO of Humana, +46 705-28 19 51, nathalie.boulas.nilsson@humana.se

Ewelina Pettersson, Head of Investor Relations, +46 730-74 79 12, ewelina.pettersson@humana.se